Association of thrombopoietin-related drugs with thromboembolic events: Mendelian randomization and a real-world study

Association of thrombopoietin-related drugs with thromboembolic events: Mendelian randomization and a real-world study

Background: Studies have shown conflicting results when using thrombopoietin-related drugs (TPORD) for thromboembolic events (TEEs). Our study aimed to explore the correlation between TPORDs and TEEs. Method: Drug-targeted Mendelian randomization (MR) and multivariate MR (MVMR) analysis were used to...

Full description

Bibliographic Details
Main Authors:	Cuilv Liang, Qiying Chen, Yin Zhang
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-01-01
Series:	Therapeutic Advances in Drug Safety
Online Access:	https://doi.org/10.1177/20420986231224236

Similar Items

Association between venous thromboembolism and atrial fibrillation: a Mendelian randomization study
by: Caijing Dang, et al.
Published: (2024-10-01)

Effects of Hyperthyroidism on Venous Thromboembolism: A Mendelian Randomization Study
by: Fushi Han, et al.
Published: (2022-01-01)

Association between migraine and venous thromboembolism: a Mendelian randomization and genetic correlation study
by: Xu-Peng Wu, et al.
Published: (2024-05-01)

Hepatitis C virus-associated thrombocytopenia is not related to serum thrombopoietin levels
by: Afifi Ola, et al.
Published: (2007-01-01)

Venous thromboembolism and severe COVID-19: a Mendelian randomization trial and transcriptomic analysis
by: Liang Chen, et al.
Published: (2024-04-01)

Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United States
by: W. Frank Peacock MD, FACEP, FACC, FESC, et al.
Published: (2022-08-01)

Cryo-EM structure of the extracellular domain of murine Thrombopoietin Receptor in complex with Thrombopoietin
by: Kaiseal T. G. Sarson-Lawrence, et al.
Published: (2024-02-01)

Venous thromboembolism and ovarian cancer risk: a Mendelian randomized study
by: Xiaolin Liu, et al.
Published: (2024-10-01)

P1635: REAL-WORLD DATA OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA) USE IN IMMUNE THROMBOCYTOPENIA (ITP)
by: S. Dangudubiyyam, et al.
Published: (2022-06-01)

Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study
by: Yong-Shuai Wang, et al.
Published: (2022-10-01)

An insight into the causal relationship between sarcopenia-related traits and venous thromboembolism: A mendelian randomization study.
by: Xinchao Du, et al.
Published: (2024-01-01)

Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study
by: Francesca Futura Bernardi, et al.
Published: (2023-10-01)

A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia
by: Qiuhua Zhu, et al.
Published: (2021-08-01)

Neutrophil count and reduced risk of venous thromboembolism: a Mendelian randomization study
by: Jiaojie Zhao, et al.
Published: (2024-12-01)

A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism
by: Lixian Ji, et al.
Published: (2023-07-01)

Thrombopoietin: tickling the HSC's fancy
by: Ah Ram Kim, et al.
Published: (2017-11-01)

A Bidirectional two-Sample Mendelian Randomization Study of the Association Between Venous Thromboembolism and Ischaemic Stroke
by: Haibing Xiong MD, et al.
Published: (2024-10-01)

Causal association between major depressive disorder and venous thromboembolism: a bidirectional mendelian randomization study
by: Hong-Yan Li, et al.
Published: (2024-06-01)

A comprehensive assessment of the association between common drugs and psychiatric disorders using Mendelian randomization and real-world pharmacovigilance databaseResearch in context
by: Zhuohui Chen, et al.
Published: (2024-09-01)

Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events
by: Najib Ben Khaled, et al.
Published: (2024-06-01)

Combination of two target agonists of the thrombopoietin and thrombopoietin receptor in the treatment of elderly patients with refractory immune thrombocytopenia
by: Jundong Zhang, et al.
Published: (2023-04-01)

Varicose Veins and Risk of Venous Thromboembolic Diseases: A Two-Sample-Based Mendelian Randomization Study
by: Ruihao Li, et al.
Published: (2022-04-01)

The causal relationships between gut microbiota and venous thromboembolism: a Mendelian randomization study
by: Pin Huang, et al.
Published: (2025-02-01)

Circulating adipokine concentrations and the risk of venous thromboembolism: A Mendelian randomization and mediation analysis
by: Weizhong Xiao, et al.
Published: (2023-03-01)

Immune-mediated inflammatory diseases and risk of venous thromboembolism: A Mendelian randomization study
by: Xiaoshuo Lv, et al.
Published: (2022-12-01)

Blood Cells and Venous Thromboembolism Risk: A Two-Sample Mendelian Randomization Study
by: Jiahao He, et al.
Published: (2022-07-01)

Association between atorvastatin and erectile dysfunction: a comprehensive analysis incorporating real-world pharmacovigilance and Mendelian randomization
by: Kaiqin Chen, et al.
Published: (2024-04-01)

Thrombopoietin is associated with δ's intercept, and only in Non‐Hispanic Whites
by: Donald R. Royall, et al.
Published: (2016-01-01)

Clinical Biology and Potential Use of Thrombopoietin
by: Russell Basser
Published: (2000-01-01)

Icaritin Provokes Serum Thrombopoietin and Downregulates Thrombopoietin/MPL of the Bone Marrow in a Mouse Model of Immune Thrombocytopenia
by: Ke Zhang, et al.
Published: (2018-01-01)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
by: Yankun Liang, et al.
Published: (2023-10-01)

Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study
by: Cooper, N, et al.
Published: (2024)

Causal association between circulating α-Klotho levels and venous thromboembolism: a two-sample Mendelian randomization study
by: Yanmin Song, et al.
Published: (2025-01-01)

Causal effect of gut microbiota on venous thromboembolism: a two-sample mendelian randomization study
by: Linfeng Xi, et al.
Published: (2024-11-01)

Causal effect of serum matrix metalloproteinase levels on venous thromboembolism: a Mendelian randomization study
by: Deheng Han, et al.
Published: (2024-04-01)

Genetically predicted basal metabolic rate and venous thromboembolism risk: a Mendelian randomization study
by: Jian Huang, et al.
Published: (2023-12-01)

Two patterns of thrombopoietin signaling suggest no coupling between platelet production and thrombopoietin reactivity in thrombocytopenia-absent radii syndrome
by: Janine Fiedler, et al.
Published: (2012-01-01)

Autoimmune disease and risk of lymphoma: analysis from real-world data and Mendelian randomization study
by: Linquan Zhan, et al.
Published: (2025-02-01)

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
by: Xue-Feng Jiao, et al.
Published: (2023-01-01)

The effect of altitude on platelets, thrombopoietin and erythropoietin in man.
by: Hudson, J, et al.
Published: (1997)